Nicholas D. Yeager, MD :: Nationwide Children’s Hospital, Columbus, Ohio

Contact Information

Hematology & Oncology
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-3250
FX: (614) 722-8826

Location Information for Patients

Main Campus


Dr. Yeager’s clinical interests include bone tumors, soft tissue sarcomas and malignancy in adolescents and young adults. He is involved with the Orthopedic Oncology Clinic, working collaboratively with Dr. Joel Mayerson and Dr. Tom Scharschmidt. He also serves as director of the pediatric hematology/oncology fellowship program. Dr. Yeager received his medical degree from Northeastern Ohio Medical University and completed his residency and fellowship training at Nationwide Children’s. Dr. Yeager is voted among the “Best Doctors in America”.


  • Male

Languages Spoken:

  • English

Research Interests

Education and Training

Medical School

  • Northeastern Ohio Universities College of Medicine
    Date Completed: 05/25/1996


  • Nationwide Children's Hospital
    Date Completed: 06/30/1997


  • Nationwide Children's Hospital
    Date Completed: 06/30/1999


  • Nationwide Children's Hospital
    Date Completed: 06/30/2000


  • Nationwide Children's Hospital
    Date Completed: 06/30/2003


  • Pediatrics


  • Hematology & Oncology


  • Pediatric Hematology Oncology
  • Pediatrics

Date of Appointment at Nationwide Children’s Hospital:

  • 07/01/2003


  • Shaw PH, Reed DR, Yeager N, et al. 2015. Adolescent and Young Adult (AYA) Oncology in the United States: A Specialty in Its Late Adolescence.  J Pediatr Hematol Oncol. Vol. epub, no. March: eepub.
  • Varga E, Chao EC, Yeager ND. 2015. The importance of proper bioinformatics analysis and clinical interpretation of tumor genomic profiling: a case study of undifferentiated sarcoma and a constitutional pathogenic BRCA2 mutation and an MLH1 variant of uncertain significance.  Familial Cancer. Vol. epub, no. February: eepub.
  • Sulkowski J, Nicol K, Raval M, Yeager N et al. 2014. Infantile fibrosarcoma of the intestine: A report of two cases and literature review.  Journal of Pediatric Surgery Case Reports. Vol. 2, no. 6. (June): 290-293.
  • Audino AN, Yeager ND. 2014. eG?A?dß0-thalassemia: a rare but clinically significant cause of hemolytic anemia in infants.  J Pediatr Hematol Oncol. Vol. 36, no. January: e49-50.
  • Anderson PM, Meyers P, Kleinerman E, Venkatakrishnan K, Hughes DP, Herzog C, Huh W, Sutphin R, Vyas YM, Shen V, Warwick A, Yeager N, Oliva C, Wang B, Liu Y, Chou A. 2013. Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.  Pediatr Blood Cancer. Vol. 61, no. August: 238-44.
  • Audino,Anthony,N; Yeager,Nicholas,D; Asti,Lindsey; Miao,Yongjie; O'Brien,Sarah,H. 2013. Length of stay and treatment-related complications are similar in pediatric and AYA patients with bone sarcoma in United States children's hospitals.  PEDIATRIC BLOOD & CANCER. Vol. 60, no. 3. (March): 415-419.
  • Miller,Kimberly,S; Vannatta,Kathryn; Vasey,Michael; Yeager,Nicholas; Compas,Bruce,E; Gerhardt,Cynthia,A. 2012. Health literacy variables related to parents' understanding of their child's cancer prognosis.  PEDIATRIC BLOOD & CANCER. Vol. 59, no. 5. (November): 914-918.
  • Streby,Keri;Whiteside,Stacy; Yeager,Nicholas. 2012. RHABDOMYOSARCOMA IN ADOLESCENTS AND YOUNG ADULTS AT NATIONWIDE CHILDREN'S HOSPITAL: A 25 YEAR REVIEW.  Journal of Adolescent and Young Adult oncology. Vol. 1, no. 4. (June): 164-167.
  • Setty,Bhuvana,A; Yeager,Nicholas,D; Bajwa,Rajinder,P. 2011. Heterozygous M1V Variant of ELA-2 Gene Mutation Associated With G-CSF Refractory Severe Congenital Neutropenia.  PEDIATRIC BLOOD & CANCER. Vol. 57, no. 3. (September): 514-515.
  • Fernandez K, Baum R, Fung B, Yeager ND, Leonis M, Wagner L, Tiao G, Ross ME. 2011. Chemoresistant Hepatoblastoma in a Patient with Mosaic Trisomy 18 Successfully Treated with Orthotopic Liver Transplant.  Pediatrc Blood and Cancer. Vol. 56, no. 3. (March): 498-500. PubMed ID: 21113936
  • yeager nd. 2011. Heterozygous M1V variant of ELA-2 gene mutation associated with severe congenital neutropenia refractory to granulocyte- colony stimulating factor.  Pediatric Blood and Cancer.
  • Termuhlen AM, Klopfenstein K, Olshefski R, Rosselet R, Yeager ND, Soni S, Gross TG. 2008. Mobilization of PML-RARA negative blood stem cells and salvage with autologous peripheral blood stem cell transplantation in children with relapsed acute promyelocytic leukemia.  Pediatr Blood Cancer.. Vol. 51, no. 4. (October): 521-524.
  • Yeager,Nicholas,D; Hammond,Sue; Mahan,John; Davis,John,Terrance; Adler,Brent. 2008. Unique diagnostic features and successful management of a patient with disseminated lymphangiomatosis and chylothorax.  JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. Vol. 30, no. 1. (January): 66-69.
  • Yeager ND, Hammond S, Mahan J, Davis JT, Adler B. 2008. Unique diagnostic features and successful management of a patient with disseminated lymphangiomatosis and chylothorax.  J Pediatr Hematol Oncol.. Vol. 30, no. 1. (January): 66-69.
  • Kalpatthi R, Germak J, Mizelle K, Yeager N. 2007. Thyroid abnormalities in infantile hepatic hemangioendothelioma.  Pediatric Blood & Cancer. Vol. 49, no. 7. (January): 1021-1024.
  • Yeager, Nicholas D MD; Hoshaw-Woodard, Stacy PhD; Ruymann, Frederick B MD; Termuhlen, Amanda MD. 2006. Patterns of Care Among Adolescents With Malignancy in Ohio.  Journal of Pediatric Hematology/Oncology. Vol. 28, no. 1. (January): 17-22.
  • Brent Adler , John Naheedy, Nicholas Yeager, Kathleen Nicol, Jan Klamar. 2005. Multifocal epithelioid hemangioendothelioma in a 16-year-old boy.  Pediatric Radiology. Vol. 35, no. 10. (October): 1014-1018.
  • Yeager ND, Dolan ME, Gastier J, Gross T, Delaney S, Frick J, Ruymann F, Ewesuedo R. 2003. 06-methylguanine-DNA methyltransferase activity and promoter methylation status in pediatric rhabdomyosarcoma.  Journal of Pediatric Hematology/Oncology. Vol. 25, no. 12. (December): 941-947.
  • Yeager,N,D; Ewesuedo,R; Ruymann,F,B; CHANG,L,S. 2003. Topoisomerase 1 activity in pediatric rhabdomyosarcoma.  PEDIATRIC RESEARCH. Vol. 53, no. 4. (April): 269A-269A.
  • Yeager,N,D; Dolan,M,E; Gastier,J,M; Ruymann,F,B; Frick,J; Delaney,S; Ewesuedo,R. 2003. AGT activity and promoter methylation status of pediatric rhabdomyosarcoma.  PEDIATRIC RESEARCH. Vol. 53, no. 4. (April): 269A-269A.
  • Ewesuedo,R; Yeager,N; Frick,J; Gastier-Foster,J. 2002. MGMT promoter methylation in pediatric rhabdomyosarcoma.  PEDIATRIC RESEARCH. Vol. 51, no. 4. (April): 246A-246A.
  • Weiner J, Horn P,Scharschmidt T, Yeager ND. Ewing Sarcoma:Presentation, Diagnosis, Treatment, and Prognosis.  Consultant for Pediatricians.
  • Yeager ND, Audino A. The Evaluation of Lung Nodules in Pediatric Bone Tumors. In Malignant Pediatric Bone Tumors –Treatment & Management. Edited by Cripe TC, Yeager ND.
  • Audino A, Yeager ND. eG?A?dß0-Thalassemia: A Rare but Clinically Significant Cause of Hemolytic Anemia in Infants.  Journal of Pediatric Hematology/Oncology. PubMed ID: 23128329
  • Lagmay J, Yeager ND. Recurrent Bone Tumors. In Malignant Pediatric Bone Tumors-Treatment and Management. Edited by Cripe TP, Yeager ND.
  • Kalpatthi R, Germak J, Mizelle K, Yeager ND. Thyroid Abnormalities in Infantile Hepatic Hemangioendothelioma: A Case Report and Review of the Literature. Pediatric Blood Cancer 49(7): 1021-4, December 2007.
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000